Yield and rate test. by Edward V. LaBelle (608387)

ATRA decreases the binding of Nrf2 to ARE sequences in the promoter regions of HO-1, GCLM and x-CT in BTZ-treated cells. by A. L. Furfaro (2587792)

Selective C−H Activation of Haloalkanes using a Rhodiumtrispyrazolylborate Complex by Andrew J. Vetter (2349535)

“…By comparing the kinetic stabilities of a series of 1-chloroalkane activation products (C₁−C₅), it was found that the chlorine substituent dramatically decreases reductive elimination rates as the substitution is closer to the metal center. …”

Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

“…(<b>A</b>) PC12 cells without (white columns) or with expression of exogenous <i>PC3</i> (activated a week before by withdrawal of 2 µg/ml of doxycycline; grey columns) were exposed to NGF (100 ng/ml) for 1 and 48 hours. …”

List of the main semi-quantified compounds (% area) from pyrolysis of A, M2.5, M5, M10 at 450ºC, 550º and 650ºC. by Sueilha F. A. Paula (13988800)

IL-19-/- mice have a decreased inflammatory response to a T cell-dependent challenge of the airways. by Carol Hoffman (196241)

Toluidine blue histology of cMSC constructs for initial chondrogenic screening. by Melissa A. MacIver (12850566)

Subjects:

Phosphatases treatment decreases rVAR2CSA and IE cytoadhesion under static and flow conditions. by Dominique Dorin-Semblat (832845)

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 4 by Jin Zhou (90734)

Inactivation of Rb leads to decreased expression of MEG3 and re-expression inhibits proliferation in A549 cells. by Traci L. Kruer (3342425)

Simulation results of magnetization difference between control and labeling scans with two flow rates (0.2 and 5 cm/s) for ALADDIN with multiphase bSSFP sequence. by Ki Hwan Kim (427869)

HDR brachytherapy decreases proliferation rate and cellular progression of a radioresistant human squamous cell carcinoma in vitro by Jony M. Geraldo (4107100)

“…</p> <p><b>Conclusion:</b> HDR brachytherapy led to a decreased proliferation rate and cell survival and also hampered cellular progression to mitosis suggesting that tumor cell death mainly occurred due to mitotic death and G₂/M cell cycle arrest.…”

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of d... by Juanjuan Li (399633)

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6 by Jin Zhou (90734)

“…<p>The effects of GSK360A on <b>(A)</b> mNSS, <b>(B)</b> beam balance, <b>(C)</b> foot fault and <b>(D)</b> hind limb performance at 5 hours, 1 day, 1 week and 3 weeks after stroke. …”

Lithiation of 2,4,5,7-Tetrabromo-1,8-bis(dimethylamino)naphthalene: Peculiarities of Directing Groups’ Effects and the Possibility of Polymetalation by Artyom A. Yakubenko (11602733)

“…It was demonstrated that the first exchange occurs in position 4 due to the significant decrease of a steric strain of the molecule. The second exchange takes place in either position 5 or 7 due to the even more negative charge distribution in the naphthalene core. …”

Activation of Wnt/β-catenin signaling decreases mRNA expressions of <i>Scx</i>, <i>Mkx</i> and <i>Tnmd</i> in rat TDCs. by Yasuzumi Kishimoto (4282138)

“…<p>Relative expressions of <i>Axin2</i>, <i>Scx</i>, <i>Mkx</i>, and <i>Tnmd</i> in TDCs treated with 50 ng/ml Wnt3a with or without 5 μM IWR (an inhibitor of β-catenin) <b>(A)</b>, 0 to 4 μM BIO (an activator of β-catenin) <b>(B)</b>, or 0 to 20 μM IWR <b>(C)</b> for 72 hrs. …”

Causal directed acyclic graph (DAG) of the relationship between time-varying exposures for example, HbA1C-SD by Khadije Maajani (10125692)

Subjects:

Original data (a, b, c, d) and disproportionality analysis results (ROR & IC). by Mengsi Peng (12882734)

S5 Fig - by Meghan J. Hirsch (16528311)

“…Our model shows with an inoculum of 2 x 10² CFUs of PA for 24 hours pro-inflammatory markers such as interleukin 6 and interleukin 8 are upregulated with little decrease in CF bronchial epithelial cell survival or monolayer confluency. …”

Prolonged transforming growth factor (TGF)-βtreatment induced a decrease in total Smad2 and/or Smad3 in many cell strains by Kimberly A Brown (26546)